Dr. Davidzon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford University Medical Center Nuclear Medicine
Palo Alto, CA 94305Phone+1 650-723-6855
Summary
- Dr. Guido Davidzon is specialized in Nuclear Medicine & Molecular Imaging in Stanford, CA. He is affiliated with Stanford Health Care and LPCH. He has been in practice 15 years. He speaks Spanish. He is experienced in diagnostic imaging using PET/CT and PET/MR scans in oncology, cardiovascular, and neurological disorders as well as in the use of targeted radionuclide therapy in cancer.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 2010 - 2013
Massachusetts Institute of TechnologySM, Biomedical Informatics, 2008 - 2010
Massachusetts General Hospital2010
Yale-New Haven Medical CenterResidency, Surgery, 2006 - 2007
Maimonides University Faculty of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2011 - 2025
IL State Medical License 2013 - 2014- American Board of Nuclear Medicine Nuclear Medicine
- Physician and Surgeon, Medical Board of California License A117782
Awards, Honors, & Recognition
- Best Essay Travel Grant Award SNM/ACNM Annual Meeting, 2012
- Young Investigator Award Symposium SNMMI, Nuclear Oncology Council, 2011
Clinical Trials
- Quantitative 13N-Ammonia Cardiac Rest/Stress Digital PET/CT Start of enrollment: 2017 Mar 29
- [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers Start of enrollment: 2018 Apr 23
- Neuroimaging GABA Physiology in Fragile X Syndrome Start of enrollment: 2016 Nov 01
Publications & Presentations
PubMed
- 23 citationsTrue ultra-low-dose amyloid PET/MRI enhanced with deep learning for clinical interpretationKevin Chen, Tyler N. Toueg, Mary Ellen I. Koran, Guido Davidzon, Michael Zeineh
European Journal of Nuclear Medicine and Molecular Imaging. 2021-01-08 - 33 citationsLow-count whole-body PET with deep learning in a multicenter and externally validated study.Akshay S. Chaudhari, Erik Mittra, Guido Davidzon, Praveen Gulaka, Harsh Gandhi
NPJ Digital Medicine. 2021-08-23 - 25 citationsGeneralization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learningKevin Chen, Matti Schürer, Jiahong Ouyang, Mary Ellen I. Koran, Guido Davidzon
European Journal of Nuclear Medicine and Molecular Imaging. 2020-06-13
Press Mentions
Stanford University Partners with Kheiron Medical Technologies to Pioneer Use of AI in New Areas of OncologyNovember 29th, 2021
Professional Memberships
- Member
- SNMMIMember
Other Languages
- Spanish
External Links
- Linkedinhttp://www.linkedin.com/in/gdavidzon/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
